Aprinocarsen

DB06451InvestigationalGene Therapies

Aprinocarsen is a specific antisense oligonucleotide inhibitor of protein kinase C-alpha.

Primary indication
Investigated for use/treatment in lung cancer.Curator reviewed
Also known as
PKC-alpha
Code names
ISIS-3521 · LY-900003

Resolves to

Compound
UNIIFMT95051CQCAS151879-73-1
Clinical / RWD
RxNorm2634355
Targets
P17252PRKCA

What you can answer from here — as of July 17, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Aprinocarsen, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In